Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: esusun, efood125, Hunchbackgeek, $Pistol Pete$, thenewmixer, fraum
Search This Board: 
Last Post: 4/19/2019 5:59:01 PM - Followers: 795 - Board type: Free - Posts Today: 76

Welcome to PharmaCyte BioTech
An OTCQB Company

http://pharmacyte.com/  

 
 
 
 
 

 

 




 
 
 
 




PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.
 

 

FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
1,127,000,000 a/o Dec 14, 2018

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

Float:
817,204,665 a/o Aug 29, 2016


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations


Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Quarterly Report (10-q) 03/14/2019 05:23:39 PM
PMCB News: Quarterly Report (10-q) 12/14/2018 05:37:56 PM
PlusOneCoin Top Posts
#92980   They are only waiting for June to throw JODI1 04/19/19 10:40:43 AM
PostSubject
#91864  Sticky Note Great news will be coming before you know longboarder7892 03/25/19 12:58:25 PM
#89647  Sticky Note $PMCB PharmaCyte Biotech Announces Encapsulation of Live $Pistol Pete$ 01/15/19 01:29:47 PM
#88890  Sticky Note $PMCB What makes Cell-in-a-Box different fro $Pistol Pete$ 12/11/18 01:41:35 PM
#93025   Hi RC , I am really not esusun 04/19/19 05:59:01 PM
#93024   Hey A2Z , my soon would esusun 04/19/19 05:56:36 PM
#93023   I like your word SOON. But soon to A2Z 04/19/19 05:10:45 PM
#93022   Just keep listening to the 15 Year longs bearspread 04/19/19 04:18:19 PM
#93021   Further, stop RESPONDING to their posts. But not rcstock 04/19/19 04:12:08 PM
#93020   Just keep listening to the 15 Year longs concordia 04/19/19 04:02:40 PM
#93019   Their next big hurdle will be trying to bearspread 04/19/19 03:55:20 PM
#93018   1234 wrote ~" And let’s stop listening to esusun 04/19/19 03:40:50 PM
#93017   Pray tell, how do you know that? Wishful Otsy 04/19/19 03:22:30 PM
#93016   Their next big hurdle will be trying to Otsy 04/19/19 03:19:53 PM
#93015   No, I never heard of it. Yes, I've Otsy 04/19/19 03:17:50 PM
#93014   So here’s your choices bearspread 04/19/19 03:00:27 PM
#93013   maybe my thinking is wrong. I don’t know A2Z 04/19/19 02:02:36 PM
#93012   Tulla...like you and everyone else on this board... efood125 04/19/19 01:54:02 PM
#93011   very well put and what really goes on Otsy 04/19/19 01:38:35 PM
#93010   why won't pmcb have a shareholders meeting? A2Z 04/19/19 01:38:07 PM
#93009   you forget #3 thenewmixer 04/19/19 01:34:38 PM
#93008   I think you hit the nail on the Otsy 04/19/19 01:28:32 PM
#93007   So here’s your choices: 1. Believe the words BioInvestor4 04/19/19 01:28:09 PM
#93006   efood, so you think we are still months away??? tulla236a 04/19/19 01:25:52 PM
#93005   And the results will be known in a thenewmixer 04/19/19 01:14:57 PM
#93004   once the operation manual is complete-gee gads LOL bearspread 04/19/19 01:00:30 PM
#93003   Fellow PMCB investors : Let me state my rcstock 04/19/19 01:00:25 PM
#93002   Keep up the good fight 123 appreciate it rayla1961 04/19/19 12:31:00 PM
#93001   And the results will be known in a efood125 04/19/19 12:13:35 PM
#93000   It sounds like we are back to pre bearspread 04/19/19 11:53:51 AM
#92997   I now remember why I stopped posting on here 1234jklm 04/19/19 11:27:46 AM
#92996   I honestly don’t blame them anymore because I 1234jklm 04/19/19 11:27:10 AM
#92995   if they were doing there job ind would thenewmixer 04/19/19 11:26:51 AM
#92994   That’s just not true. 1234jklm 04/19/19 11:26:17 AM
#92993   The experts are doing a job they know 1234jklm 04/19/19 11:21:13 AM
#92992   Because they have absolutely no regard for SH. rcstock 04/19/19 11:17:42 AM
#92991   DUH !!! They said process optimization is underway. rcstock 04/19/19 11:16:18 AM
#92990   why won't pmcb have a shareholders meeting? or thenewmixer 04/19/19 11:15:05 AM
#92989   Obviously not. Maybe for the encapsulation piece. rcstock 04/19/19 11:12:06 AM
#92987   And it’s cgmp by the way 1234jklm 04/19/19 11:06:01 AM
#92986   No. You’re reading things into it to confirm 1234jklm 04/19/19 11:05:13 AM
#92985   No. They are very very close now. 1234jklm 04/19/19 11:02:15 AM
#92984   This is not pre production. It’s post production. 1234jklm 04/19/19 11:00:40 AM
#92983   Didnt they already meet those standards ace1234 04/19/19 10:58:18 AM
#92982   Read the post again people. PROCESS optimization to rcstock 04/19/19 10:49:45 AM
#92981   I will gladly send you the email from concordia 04/19/19 10:42:58 AM
#92980   They are only waiting for June to throw JODI1 04/19/19 10:40:43 AM
#92979   That’s the real question here, is the production BioInvestor4 04/19/19 10:31:55 AM
#92978   There is nothing to suggest they’ve hit a problem. bearspread 04/19/19 10:13:40 AM
#92977   Not my job. 1234jklm 04/19/19 10:12:38 AM
#92976   This is full of illogical errors.-then refute the_post bearspread 04/19/19 10:04:53 AM
#92975   It must be a GMP issue. bearspread 04/19/19 10:01:42 AM
#92974   This is full of illogical errors. 1234jklm 04/19/19 09:51:28 AM
#92973   I think everything is moving forward...slow...yes. efood125 04/19/19 09:50:53 AM
PostSubject